SLGL
Sol-Gel Technologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$60.00
−7.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 170.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.08x
- Price / sales
- 109.44x
- Price / cash flow
- 610.06x
Enterprise value
- Enterprise value
- $149.3M
- EV / sales
- 83.16x
- EV / EBITDA
- -8.59x
- EV / EBIT
- -8.43x
- Market cap
- $196.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026